In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Calypso's latest venture round brings in $50mm

Executive Summary

Calypso Medical Technologies (implantable devices for tumor localization and monitoring) raised $48.4mm through a venture round co-led by founding backer Frazier Healthcare Venture and new investor Skyline Ventures. First-time buyer InterWest Partners also participated, along with existing investors Bay City Capital, Versant Ventures, BB Biotech, Arnerich Massena & Associates, Apothecary Capital, RiverVest Ventures, Merlin Nexus, Early Bird Ventures, Glenview Capital Management, Integra Ventures, AEOW, Kaiser Permanente Ventures, Mosaix Ventures, SB Life Science Ventures, Mitsui & Co. Venture Partners, Rockport Ventures, and 21 other investors.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies